Pharmaceutical R&D Productivity Forum 2008
20th - 21st October 2008
Hyatt San Diego, California
Optimizing R&D pipelines
Advisory Board
We work closely with a chosen panel of leading experts and practitioners to put together a timely relevant programme which truly reflects today’s key industry concerns and are constantly seeking industry feedback and new contacts to join the advisory board. Members meet a few times a year, either as a group or on a one-to-one basis to help drive the programmes to ensure it reflects the key industry concerns.
The board continually help review and mould our conference programmes, drawing upon their wealth of experience to advise on current industry developments and potential speakers, with many taking part in the event themselves.
Current PPF Advisory Board Members Include
 |
Dr Alan Sachs Vice President, RNA Therapeutics and Molecular Profiling, Merck & Co. |
 |
Dr. Hans-Joachim Böhm President, Roche Palo Alto, & Global Head of Chemistry, Roche |
 |
William B. Mattes PhD, DABT Director of C-Path’s Predictive Safety Testing, Consortium (PSTC), Critical Path Institute |
 |
Scott D. Patterson PhD Executive Director, Medical Sciences, Amgen Inc. |
 |
Jilly Evans Ph.D. Vice President, Biology, Co-Founder, Amira Pharmaceuticals |
 |
Dr. Samuel Broder Chief Medical Officer,Celera, Former Director of the National Cancer Institute, 1989-1995 |
 |
Dr Michael O’Callaghan Vice President, R&D Genzyme |
 |
Dr Vadim Bichko Vice President, Virology ChemDiv, Inc. |
Application for membership
We are continually seeking new members to join our advisory boards. If you would like more information or would like to help drive the conference programme by becoming an Advisory Board member, please contact
Thea Austin thea.austin@wtgevents.com, Conference Producer, , T: +1 416 214 1693
Please note acceptance onto the advisory board is not automatic and each enquiry will be judged on its own merit. The Advisory Board reserves the right to reject applications based on incomplete or unverifiable information.
